#GeneralMotors on Wednesday (Feb 6) reported better-than-expected #earnings for Q4, results that will draw a stark comparison to #FordMotor Co, which is struggling to grow profit after several quarters of declines. Still, weak spots in the report show #GM is not immune to the struggles that are affecting #carmakers around the world. International sales dipped from the prior year, underscored by a 21.7% decline in Asia to 1.1 million vehicles. U.S. sales also slid slightly in the 3 months through December, but adjusted earnings for North America inched up YoY - supported by a record average $36,000 transaction price in America. Revenue at the Detroit-based company grew 1.8 percent to $38.4bn. Adjusted profits were $2.8bn, or $1.43 per share, down from the prior year but exceeding Wall Street predictions.


#CorporateEarnings #ShareholderReturn #FinancialReporting #CorporateProfits #Profits #AmericanCompanies #Auto #AutoIndustry #AutoCompanies #Automotive
GM exceeds Wall Street earnings estimates despite slower China, US sales
https://www.foxbusiness.com/industrials/gm-exceeds-wall-street-earnings-estimates

#GeneralMotors delivered a positive jolt to Wall Street on Wednesday (Feb 6) morning when it announced strong earnings for both Q4 and full year. The strong numbers, however, could further stoke criticism of Detroit’s largest automaker, coming at a time when it is laying off thousands of workers and preparing to close three assembly and two parts plants.

For Q4 of 2018, #GM delivered #earnings of $1.43 a share - $1.40 after excluding special items. For the full year, earnings came to $6.54 a share, well ahead of the consensus forecast of $6.29. After special charges, the figure dropped to $5.58 per share. GM’s overall $8.1bn profit for all of 2018 was more than double the $3.9bn number from the year before.


#CorporateEarnings #ShareholderReturn #FinancialReporting #CorporateProfits #Profits #AmericanCompanies #Auto #AutoIndustry #AutoCompanies #Automotive
GM surprises Wall Street with strong earnings
https://www.nbcnews.com/business/autos/gm-surprises-wall-street-strong-earnings-n968341

#Twitter posted Q4 earnings of 16 cents per share on revenue of $717m. The company adjusted its EBITDA guidance for Q1 in the range of $75m to $95m. Wall Street expected an estimate of $191.3m. Twitter said total advertising revenue was $638m, down slightly from a year earlier. U.S. revenue totaled $440m, a YoY decrease of 5%. International revenue totaled $277m, an increase of 12% from the previous year.


#CorporateEarnings #ShareholderReturn #FinancialReporting #Earnings #CorporateProfits #Technology #TechCompanies
Twitter shares crater after ugly revenue miss, shockingly weak guidance
http://www.cnbc.com/2017/02/09/twitter-earnings-16-cents-a-share-vs-12-cents-estimate.html

#Walmart is taking on Amazon in an attempt to head off the online giant before it can gain too much of a foothold in the home-delivered #grocery business. Overall, WalMart revenue rose 2.1% to $123.4bn. Sales at Walmart U.S. stores open at least a year rose 1.8%, meeting projections. But net income tumbled 23.2% to $2.9bn, or 96 cents per share, missing projections of $3.2bn and $1.06 per share. That decline reflected a 17-cent-a-share charge related to the dispatching of debt. Adjusted earnings were $1.08 per share.


#CorporateEarnings #ShareholderReturn #FinancialReporting #CorporateProfits #Retailing #RetailingIndustry #Retailers
With Amazon looming, Walmart touts surging online grocery sales
https://www.usatoday.com/story/money/2017/08/17/walmart-second-quarter-earnings/569634001/

#Pfizer, the largest U.S. #drugmaker, reported a bigger-than-expected quarterly profit, helped by higher sales of breast cancer drug Ibrance and pain relief drug Lyrica. Ibrance, which is expected to face competition from rival Novartis' recently approved treatment Kisqali, generated sales of $679m, a 58.3% rise from the year-ago quarter. Pfizer said net profit rose to $3.12bn, or 51 cents per share, in Q1, from $3.04bn, or 49 cents per share, a year earlier.


#CorporateEarnings #ShareholderReturn #FinancialReporting #CorporateProfits #Earnings #Pharmaceutical #Pharma #BigPharma
Pfizer beats first-quarter profit estimates
http://www.cnbc.com/2017/05/02/pfizers-quarterly-profit-rises.html

#Merck posted adjusted earnings of 88 cents per share on $9.4bn in revenue. In last year’s Q1, the drug maker posted $9.3bn in revenue and 89 cents per share. #Pfizer reported adjusted earnings of 69 cents per share on $12.8bn in revenue. In last year’s Q1, the drug company posted $13bn in revenue.

Merck’s GAAP EPS rose to 56 cents from 40 cents per share in last year’s Q1. Pharmaceutical revenue rose 1% to $8.2bn, which includes a negative impact of 1% from currency headwinds. Merck also increased its full-year adjusted earnings guidance to a range of $3.76 to $3.88 per share, up from $3.72 to $3.87 per share. The drug maker also boosted its revenue guide for the full year to between $39.1bn and $40.3bn from the previous outlook of $38.6bn to $40.1bn. The company expects a negative impact of about 1.5% from currency headwinds on both earnings and revenue.


#CorporateEarnings #ShareholderReturn #FinancialReporting #CorporateProfits #Earnings #Pharmaceutical #Pharma #BigPharma
Pfizer Inc Shares Rise After Earnings, Merck & Co., Inc. Shares Decline
http://www.valuewalk.com/2017/05/pfizer-rise-earnings-merck-decline/